Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.06−0.43 (-5.06%)
Close on Nov 18, 2026Market cap $1.47BP/E –Yield –
Teladoc Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Teladoc Health's revenue for the twelve months ending Sep 30, 2026 was $2.47B, down 2.4% year over year. For fiscal 2025 it was $2.53B, down 1.5% from the year before. Over ten years it grew 41.7% a year on average. The highest annual figure on record is $2.60B in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | -1.5% |
| FY2024 | Dec 31, 2024 | $2.57B | -1.3% |
| FY2023 | Dec 31, 2023 | $2.60B | +8.1% |
| FY2022 | Dec 31, 2022 | $2.41B | +18.4% |
| FY2021 | Dec 31, 2021 | $2.03B | +85.8% |
| FY2020 | Dec 31, 2020 | $1.09B | +97.7% |
| FY2019 | Dec 31, 2019 | $553.31M | +32.4% |
| FY2018 | Dec 31, 2018 | $417.91M | +79.1% |
| FY2017 | Dec 31, 2017 | $233.28M | +89.4% |
| FY2016 | Dec 31, 2016 | $123.16M | +59.2% |
| FY2015 | Dec 31, 2015 | $77.38M | +77.8% |
| FY2014 | Dec 31, 2014 | $43.53M | +118.7% |
| FY2013 | Dec 31, 2013 | $19.91M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $605.10M | -3.4% |
| Q2 FY2026 | Jun 30, 2026 | $606.93M | -4.0% |
| Q1 FY2026 | Mar 31, 2026 | $613.85M | -2.5% |
| Q4 FY2025 | Dec 31, 2025 | $642.27M | +0.3% |
| Q3 FY2025 | Sep 30, 2025 | $626.44M | -2.2% |
| Q2 FY2025 | Jun 30, 2025 | $631.90M | -1.6% |
| Q1 FY2025 | Mar 31, 2025 | $629.37M | -2.6% |
| Q4 FY2024 | Dec 31, 2024 | $640.49M | -3.0% |
| Q3 FY2024 | Sep 30, 2024 | $640.51M | -3.0% |
| Q2 FY2024 | Jun 30, 2024 | $642.44M | -1.5% |
| Q1 FY2024 | Mar 31, 2024 | $646.13M | +2.7% |
| Q4 FY2023 | Dec 31, 2023 | $660.53M | +3.6% |
| Q3 FY2023 | Sep 30, 2023 | $660.24M | +8.0% |
| Q2 FY2023 | Jun 30, 2023 | $652.41M | +10.1% |
| Q1 FY2023 | Mar 31, 2023 | $629.24M | +11.3% |
| Q4 FY2022 | Dec 31, 2022 | $637.71M | +15.1% |
| Q3 FY2022 | Sep 30, 2022 | $611.40M | +17.2% |
| Q2 FY2022 | Jun 30, 2022 | $592.38M | +17.7% |
| Q1 FY2022 | Mar 31, 2022 | $565.35M | +24.6% |
| Q4 FY2021 | Dec 31, 2021 | $554.24M | +44.6% |
| Q3 FY2021 | Sep 30, 2021 | $521.66M | +80.6% |
| Q2 FY2021 | Jun 30, 2021 | $503.14M | +108.7% |
| Q1 FY2021 | Mar 31, 2021 | $453.68M | +150.9% |
| Q4 FY2020 | Dec 31, 2020 | $383.32M | +145.0% |
| Q3 FY2020 | Sep 30, 2020 | $288.81M | +109.3% |
| Q2 FY2020 | Jun 30, 2020 | $241.03M | +85.0% |
| Q1 FY2020 | Mar 31, 2020 | $180.80M | +40.6% |
| Q4 FY2019 | Dec 31, 2019 | $156.49M | +27.5% |
| Q3 FY2019 | Sep 30, 2019 | $137.97M | +24.3% |
| Q2 FY2019 | Jun 30, 2019 | $130.28M | +37.8% |
| Q1 FY2019 | Mar 31, 2019 | $128.57M | +43.4% |
| Q4 FY2018 | Dec 31, 2018 | $122.74M | +59.1% |
| Q3 FY2018 | Sep 30, 2018 | $110.96M | +61.6% |
| Q2 FY2018 | Jun 30, 2018 | $94.56M | +112.1% |
| Q1 FY2018 | Mar 31, 2018 | $89.64M | +109.0% |
| Q4 FY2017 | Dec 31, 2017 | $77.14M | +106.3% |
| Q3 FY2017 | Sep 30, 2017 | $68.65M | – |
| Q2 FY2017 | Jun 30, 2017 | $44.59M | – |
| Q1 FY2017 | Mar 31, 2017 | $42.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.40M | – |
See a number that looks wrong?